Peter Marks, former head of FDA’s Center for Biologics Evaluation & Research, stepped down amid criticism that the agency’s vaccine approval process was influenced by pharmaceutical industry interests. Marks cited pressure from media, politicians, and the public for prioritizing vaccines over a COVID-19 pill. #FDA
0